Company to receive up to $20 million in upfront and milestone payments from non-dilutive transactionTransaction extends cash runway into 2022NEW...
To present recent progress of clinical pipeline at the H.C. Wainwright Bioconnect ConferenceWill participate in LifeSci Advisors’ 10th Annual LifeSci...
MARIETTA, Ga., Jan. 04, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader...
With over 20 years of experience in the consumer packaged goods industry, Mr. Lerner has previously held positions at PepsiCo,...
WARREN, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and...
Partnership provides US government facilities access and product distribution supportFRAMINGHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc....
Inovalon Continues Longstanding Support of Local and National Organizations through Social Responsibility Program BOWIE, Md., Jan. 04, 2021 (GLOBE NEWSWIRE)...
Topline data for two studies of KB109 are expected in the first quarter of 2021LEXINGTON, Mass., Jan. 04, 2021 (GLOBE...
PALO ALTO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced that leading proxy advisory...
HDF Assist Device Complete; Special 510(k) to be Filed in Early 2021 Nephros Granted Patent Covering Technology in HDF Assist...
NEWTOWN, Pa., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech...
DEVON, Pa., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid...
HPN328, Harpoon’s fourth TriTAC® T cell engager, enters clinical developmentSOUTH SAN FRANCISCO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Harpoon...
DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to...
SALT LAKE CITY, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Paul J. Diaz, president and CEO of Myriad Genetics, Inc. (NASDAQ:...
COPENHAGEN, Denmark, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative...
FDA clearance marks second regulatory authorization for global Phase 1/2 clinical trial, Imagine-1 study, expected to dose first patient in first...
- Company also reports inducement grant under Nasdaq Listing Rule 5635(c)(4) - RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2021 (GLOBE...
SANTA CLARA, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated...
BEDMINSTER, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused...